Global Newborn Screening for SMA and SCID Market Research Report 2026(Status and Outlook)
Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn?t otherwise apparent at birth.Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn?t otherwise apparent at birth.Severe combined immunodeficiency (SCID) is a group of rare disorders caused by mutations in different genes involved in the development and function of infection-fighting immune cells. Infants with SCID appear healthy at birth but are highly susceptible to severe infections.Spinal muscular atrophy (SMA) is a group of hereditary diseases that progressively destroys motor neurons?nerve cells in the brain stem and spinal cord that control essential skeletal muscle activity such as speaking, walking, breathing, and swallowing, leading to muscle weakness and atrophy.Global key players providing newborn screening for SMA and SCID are Perkinelmer, Thermo Fisher, ImmunoIVD, and Labsystems Diagnostics. The top four companies together hold 90% of the market share, with the largest vendor being Perkinelmer with 60% of the market share. The global companies providing newborn SMA and SCID screening are mainly located in North America and Europe, with North America holding the largest market share with 60%. In terms of product categories, kits dominate the market with 60% market share, followed by instruments and software with 35% and 5% market share, respectively. In terms of applications, SCID screening holds a 65% market share, while SMA screening is 35%.
The global Newborn Screening for SMA and SCID market size was estimated at USD 165.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 11.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Newborn Screening for SMA and SCID market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Newborn Screening for SMA and SCID market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Newborn Screening for SMA and SCID market.
Global Newborn Screening for SMA and SCID Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Perkinelmer
Thermo Fisher
ImmunoIVD
Labsystems Diagnostics
Market Segmentation (by Type)
Instruments
Kits
Software
Market Segmentation (by Application)
SCID Screening
SMA Screening
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Newborn Screening for SMA and SCID Market
Overview of the regional outlook of the Newborn Screening for SMA and SCID Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Newborn Screening for SMA and SCID Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Newborn Screening for SMA and SCID, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Newborn Screening for SMA and SCID market size was estimated at USD 165.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 11.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Newborn Screening for SMA and SCID market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Newborn Screening for SMA and SCID market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Newborn Screening for SMA and SCID market.
Global Newborn Screening for SMA and SCID Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Perkinelmer
Thermo Fisher
ImmunoIVD
Labsystems Diagnostics
Market Segmentation (by Type)
Instruments
Kits
Software
Market Segmentation (by Application)
SCID Screening
SMA Screening
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Newborn Screening for SMA and SCID Market
Overview of the regional outlook of the Newborn Screening for SMA and SCID Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Newborn Screening for SMA and SCID Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Newborn Screening for SMA and SCID, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Newborn Screening for SMA and SCID
1.2 Key Market Segments
1.2.1 Newborn Screening for SMA and SCID Segment by Type
1.2.2 Newborn Screening for SMA and SCID Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEWBORN SCREENING FOR SMA AND SCID MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Newborn Screening for SMA and SCID Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Newborn Screening for SMA and SCID Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEWBORN SCREENING FOR SMA AND SCID MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Newborn Screening for SMA and SCID Product Life Cycle
3.3 Global Newborn Screening for SMA and SCID Sales by Manufacturers (2020-2025)
3.4 Global Newborn Screening for SMA and SCID Revenue Market Share by Manufacturers (2020-2025)
3.5 Newborn Screening for SMA and SCID Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Newborn Screening for SMA and SCID Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Newborn Screening for SMA and SCID Market Competitive Situation and Trends
3.8.1 Newborn Screening for SMA and SCID Market Concentration Rate
3.8.2 Global 5 and 10 Largest Newborn Screening for SMA and SCID Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NEWBORN SCREENING FOR SMA AND SCID INDUSTRY CHAIN ANALYSIS
4.1 Newborn Screening for SMA and SCID Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEWBORN SCREENING FOR SMA AND SCID MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Newborn Screening for SMA and SCID Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Newborn Screening for SMA and SCID Market
5.7 ESG Ratings of Leading Companies
6 NEWBORN SCREENING FOR SMA AND SCID MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Newborn Screening for SMA and SCID Sales Market Share by Type (2020-2025)
6.3 Global Newborn Screening for SMA and SCID Market Size by Type (2020-2025)
6.4 Global Newborn Screening for SMA and SCID Price by Type (2020-2025)
7 NEWBORN SCREENING FOR SMA AND SCID MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Newborn Screening for SMA and SCID Market Sales by Application (2020-2025)
7.3 Global Newborn Screening for SMA and SCID Market Size (M USD) by Application (2020-2025)
7.4 Global Newborn Screening for SMA and SCID Sales Growth Rate by Application (2020-2025)
8 NEWBORN SCREENING FOR SMA AND SCID MARKET SALES BY REGION
8.1 Global Newborn Screening for SMA and SCID Sales by Region
8.1.1 Global Newborn Screening for SMA and SCID Sales by Region
8.1.2 Global Newborn Screening for SMA and SCID Sales Market Share by Region
8.2 Global Newborn Screening for SMA and SCID Market Size by Region
8.2.1 Global Newborn Screening for SMA and SCID Market Size by Region
8.2.2 Global Newborn Screening for SMA and SCID Market Size by Region
8.3 North America
8.3.1 North America Newborn Screening for SMA and SCID Sales by Country
8.3.2 North America Newborn Screening for SMA and SCID Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Newborn Screening for SMA and SCID Sales by Country
8.4.2 Europe Newborn Screening for SMA and SCID Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Newborn Screening for SMA and SCID Sales by Region
8.5.2 Asia Pacific Newborn Screening for SMA and SCID Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Newborn Screening for SMA and SCID Sales by Country
8.6.2 South America Newborn Screening for SMA and SCID Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Newborn Screening for SMA and SCID Sales by Region
8.7.2 Middle East and Africa Newborn Screening for SMA and SCID Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NEWBORN SCREENING FOR SMA AND SCID MARKET PRODUCTION BY REGION
9.1 Global Production of Newborn Screening for SMA and SCID by Region(2020-2025)
9.2 Global Newborn Screening for SMA and SCID Revenue Market Share by Region (2020-2025)
9.3 Global Newborn Screening for SMA and SCID Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Newborn Screening for SMA and SCID Production
9.4.1 North America Newborn Screening for SMA and SCID Production Growth Rate (2020-2025)
9.4.2 North America Newborn Screening for SMA and SCID Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Newborn Screening for SMA and SCID Production
9.5.1 Europe Newborn Screening for SMA and SCID Production Growth Rate (2020-2025)
9.5.2 Europe Newborn Screening for SMA and SCID Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Newborn Screening for SMA and SCID Production (2020-2025)
9.6.1 Japan Newborn Screening for SMA and SCID Production Growth Rate (2020-2025)
9.6.2 Japan Newborn Screening for SMA and SCID Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Newborn Screening for SMA and SCID Production (2020-2025)
9.7.1 China Newborn Screening for SMA and SCID Production Growth Rate (2020-2025)
9.7.2 China Newborn Screening for SMA and SCID Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Perkinelmer
10.1.1 Perkinelmer Basic Information
10.1.2 Perkinelmer Newborn Screening for SMA and SCID Product Overview
10.1.3 Perkinelmer Newborn Screening for SMA and SCID Product Market Performance
10.1.4 Perkinelmer Business Overview
10.1.5 Perkinelmer SWOT Analysis
10.1.6 Perkinelmer Recent Developments
10.2 Thermo Fisher
10.2.1 Thermo Fisher Basic Information
10.2.2 Thermo Fisher Newborn Screening for SMA and SCID Product Overview
10.2.3 Thermo Fisher Newborn Screening for SMA and SCID Product Market Performance
10.2.4 Thermo Fisher Business Overview
10.2.5 Thermo Fisher SWOT Analysis
10.2.6 Thermo Fisher Recent Developments
10.3 ImmunoIVD
10.3.1 ImmunoIVD Basic Information
10.3.2 ImmunoIVD Newborn Screening for SMA and SCID Product Overview
10.3.3 ImmunoIVD Newborn Screening for SMA and SCID Product Market Performance
10.3.4 ImmunoIVD Business Overview
10.3.5 ImmunoIVD SWOT Analysis
10.3.6 ImmunoIVD Recent Developments
10.4 Labsystems Diagnostics
10.4.1 Labsystems Diagnostics Basic Information
10.4.2 Labsystems Diagnostics Newborn Screening for SMA and SCID Product Overview
10.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Product Market Performance
10.4.4 Labsystems Diagnostics Business Overview
10.4.5 Labsystems Diagnostics Recent Developments
11 NEWBORN SCREENING FOR SMA AND SCID MARKET FORECAST BY REGION
11.1 Global Newborn Screening for SMA and SCID Market Size Forecast
11.2 Global Newborn Screening for SMA and SCID Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Newborn Screening for SMA and SCID Market Size Forecast by Country
11.2.3 Asia Pacific Newborn Screening for SMA and SCID Market Size Forecast by Region
11.2.4 South America Newborn Screening for SMA and SCID Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Newborn Screening for SMA and SCID by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Newborn Screening for SMA and SCID Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Newborn Screening for SMA and SCID by Type (2026-2035)
12.1.2 Global Newborn Screening for SMA and SCID Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Newborn Screening for SMA and SCID by Type (2026-2035)
12.2 Global Newborn Screening for SMA and SCID Market Forecast by Application (2026-2035)
12.2.1 Global Newborn Screening for SMA and SCID Sales (K MT) Forecast by Application
12.2.2 Global Newborn Screening for SMA and SCID Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Newborn Screening for SMA and SCID
1.2 Key Market Segments
1.2.1 Newborn Screening for SMA and SCID Segment by Type
1.2.2 Newborn Screening for SMA and SCID Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEWBORN SCREENING FOR SMA AND SCID MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Newborn Screening for SMA and SCID Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Newborn Screening for SMA and SCID Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEWBORN SCREENING FOR SMA AND SCID MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Newborn Screening for SMA and SCID Product Life Cycle
3.3 Global Newborn Screening for SMA and SCID Sales by Manufacturers (2020-2025)
3.4 Global Newborn Screening for SMA and SCID Revenue Market Share by Manufacturers (2020-2025)
3.5 Newborn Screening for SMA and SCID Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Newborn Screening for SMA and SCID Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Newborn Screening for SMA and SCID Market Competitive Situation and Trends
3.8.1 Newborn Screening for SMA and SCID Market Concentration Rate
3.8.2 Global 5 and 10 Largest Newborn Screening for SMA and SCID Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NEWBORN SCREENING FOR SMA AND SCID INDUSTRY CHAIN ANALYSIS
4.1 Newborn Screening for SMA and SCID Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEWBORN SCREENING FOR SMA AND SCID MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Newborn Screening for SMA and SCID Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Newborn Screening for SMA and SCID Market
5.7 ESG Ratings of Leading Companies
6 NEWBORN SCREENING FOR SMA AND SCID MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Newborn Screening for SMA and SCID Sales Market Share by Type (2020-2025)
6.3 Global Newborn Screening for SMA and SCID Market Size by Type (2020-2025)
6.4 Global Newborn Screening for SMA and SCID Price by Type (2020-2025)
7 NEWBORN SCREENING FOR SMA AND SCID MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Newborn Screening for SMA and SCID Market Sales by Application (2020-2025)
7.3 Global Newborn Screening for SMA and SCID Market Size (M USD) by Application (2020-2025)
7.4 Global Newborn Screening for SMA and SCID Sales Growth Rate by Application (2020-2025)
8 NEWBORN SCREENING FOR SMA AND SCID MARKET SALES BY REGION
8.1 Global Newborn Screening for SMA and SCID Sales by Region
8.1.1 Global Newborn Screening for SMA and SCID Sales by Region
8.1.2 Global Newborn Screening for SMA and SCID Sales Market Share by Region
8.2 Global Newborn Screening for SMA and SCID Market Size by Region
8.2.1 Global Newborn Screening for SMA and SCID Market Size by Region
8.2.2 Global Newborn Screening for SMA and SCID Market Size by Region
8.3 North America
8.3.1 North America Newborn Screening for SMA and SCID Sales by Country
8.3.2 North America Newborn Screening for SMA and SCID Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Newborn Screening for SMA and SCID Sales by Country
8.4.2 Europe Newborn Screening for SMA and SCID Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Newborn Screening for SMA and SCID Sales by Region
8.5.2 Asia Pacific Newborn Screening for SMA and SCID Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Newborn Screening for SMA and SCID Sales by Country
8.6.2 South America Newborn Screening for SMA and SCID Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Newborn Screening for SMA and SCID Sales by Region
8.7.2 Middle East and Africa Newborn Screening for SMA and SCID Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NEWBORN SCREENING FOR SMA AND SCID MARKET PRODUCTION BY REGION
9.1 Global Production of Newborn Screening for SMA and SCID by Region(2020-2025)
9.2 Global Newborn Screening for SMA and SCID Revenue Market Share by Region (2020-2025)
9.3 Global Newborn Screening for SMA and SCID Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Newborn Screening for SMA and SCID Production
9.4.1 North America Newborn Screening for SMA and SCID Production Growth Rate (2020-2025)
9.4.2 North America Newborn Screening for SMA and SCID Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Newborn Screening for SMA and SCID Production
9.5.1 Europe Newborn Screening for SMA and SCID Production Growth Rate (2020-2025)
9.5.2 Europe Newborn Screening for SMA and SCID Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Newborn Screening for SMA and SCID Production (2020-2025)
9.6.1 Japan Newborn Screening for SMA and SCID Production Growth Rate (2020-2025)
9.6.2 Japan Newborn Screening for SMA and SCID Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Newborn Screening for SMA and SCID Production (2020-2025)
9.7.1 China Newborn Screening for SMA and SCID Production Growth Rate (2020-2025)
9.7.2 China Newborn Screening for SMA and SCID Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Perkinelmer
10.1.1 Perkinelmer Basic Information
10.1.2 Perkinelmer Newborn Screening for SMA and SCID Product Overview
10.1.3 Perkinelmer Newborn Screening for SMA and SCID Product Market Performance
10.1.4 Perkinelmer Business Overview
10.1.5 Perkinelmer SWOT Analysis
10.1.6 Perkinelmer Recent Developments
10.2 Thermo Fisher
10.2.1 Thermo Fisher Basic Information
10.2.2 Thermo Fisher Newborn Screening for SMA and SCID Product Overview
10.2.3 Thermo Fisher Newborn Screening for SMA and SCID Product Market Performance
10.2.4 Thermo Fisher Business Overview
10.2.5 Thermo Fisher SWOT Analysis
10.2.6 Thermo Fisher Recent Developments
10.3 ImmunoIVD
10.3.1 ImmunoIVD Basic Information
10.3.2 ImmunoIVD Newborn Screening for SMA and SCID Product Overview
10.3.3 ImmunoIVD Newborn Screening for SMA and SCID Product Market Performance
10.3.4 ImmunoIVD Business Overview
10.3.5 ImmunoIVD SWOT Analysis
10.3.6 ImmunoIVD Recent Developments
10.4 Labsystems Diagnostics
10.4.1 Labsystems Diagnostics Basic Information
10.4.2 Labsystems Diagnostics Newborn Screening for SMA and SCID Product Overview
10.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Product Market Performance
10.4.4 Labsystems Diagnostics Business Overview
10.4.5 Labsystems Diagnostics Recent Developments
11 NEWBORN SCREENING FOR SMA AND SCID MARKET FORECAST BY REGION
11.1 Global Newborn Screening for SMA and SCID Market Size Forecast
11.2 Global Newborn Screening for SMA and SCID Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Newborn Screening for SMA and SCID Market Size Forecast by Country
11.2.3 Asia Pacific Newborn Screening for SMA and SCID Market Size Forecast by Region
11.2.4 South America Newborn Screening for SMA and SCID Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Newborn Screening for SMA and SCID by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Newborn Screening for SMA and SCID Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Newborn Screening for SMA and SCID by Type (2026-2035)
12.1.2 Global Newborn Screening for SMA and SCID Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Newborn Screening for SMA and SCID by Type (2026-2035)
12.2 Global Newborn Screening for SMA and SCID Market Forecast by Application (2026-2035)
12.2.1 Global Newborn Screening for SMA and SCID Sales (K MT) Forecast by Application
12.2.2 Global Newborn Screening for SMA and SCID Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Newborn Screening for SMA and SCID Market Size by Type (M USD)
Table 4. Global Newborn Screening for SMA and SCID Market Size by Application
Table 5. Newborn Screening for SMA and SCID Market Size Comparison by Region (M USD)
Table 6. Global Newborn Screening for SMA and SCID Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Newborn Screening for SMA and SCID Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Newborn Screening for SMA and SCID Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Newborn Screening for SMA and SCID Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Screening for SMA and SCID as of 2025)
Table 11. Global Market Newborn Screening for SMA and SCID Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Newborn Screening for SMA and SCID Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Newborn Screening for SMA and SCID Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Newborn Screening for SMA and SCID Sales by Type (K MT)
Table 27. Global Newborn Screening for SMA and SCID Market Size by Type (M USD)
Table 28. Global Newborn Screening for SMA and SCID Sales (K MT) by Type (2020-2025)
Table 29. Global Newborn Screening for SMA and SCID Sales Market Share by Type (2020-2025)
Table 30. Global Newborn Screening for SMA and SCID Market Size (M USD) by Type (2020-2025)
Table 31. Global Newborn Screening for SMA and SCID Market Share by Type (2020-2025)
Table 32. Global Newborn Screening for SMA and SCID Price (USD/KG) by Type (2020-2025)
Table 33. Global Newborn Screening for SMA and SCID Sales (K MT) by Application
Table 34. Global Newborn Screening for SMA and SCID Market Size by Application
Table 35. Global Newborn Screening for SMA and SCID Sales by Application (2020-2025) & (K MT)
Table 36. Global Newborn Screening for SMA and SCID Sales Market Share by Application (2020-2025)
Table 37. Global Newborn Screening for SMA and SCID Market Size by Application (2020-2025) & (M USD)
Table 38. Global Newborn Screening for SMA and SCID Market Share by Application (2020-2025)
Table 39. Global Newborn Screening for SMA and SCID Sales Growth Rate by Application (2020-2025)
Table 40. Global Newborn Screening for SMA and SCID Sales by Region (2020-2025) & (K MT)
Table 41. Global Newborn Screening for SMA and SCID Sales Market Share by Region (2020-2025)
Table 42. Global Newborn Screening for SMA and SCID Market Size by Region (2020-2025) & (M USD)
Table 43. Global Newborn Screening for SMA and SCID Market Size by Region (2020-2025)
Table 44. North America Newborn Screening for SMA and SCID Sales by Country (2020-2025) & (K MT)
Table 45. North America Newborn Screening for SMA and SCID Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Newborn Screening for SMA and SCID Sales by Country (2020-2025) & (K MT)
Table 47. Europe Newborn Screening for SMA and SCID Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Newborn Screening for SMA and SCID Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Newborn Screening for SMA and SCID Market Size by Region (2020-2025) & (M USD)
Table 50. South America Newborn Screening for SMA and SCID Sales by Country (2020-2025) & (K MT)
Table 51. South America Newborn Screening for SMA and SCID Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Newborn Screening for SMA and SCID Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Newborn Screening for SMA and SCID Market Size by Region (2020-2025) & (M USD)
Table 54. Global Newborn Screening for SMA and SCID Production (K MT) by Region(2020-2025)
Table 55. Global Newborn Screening for SMA and SCID Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Newborn Screening for SMA and SCID Revenue Market Share by Region (2020-2025)
Table 57. Global Newborn Screening for SMA and SCID Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Newborn Screening for SMA and SCID Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Newborn Screening for SMA and SCID Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Newborn Screening for SMA and SCID Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Newborn Screening for SMA and SCID Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Perkinelmer Basic Information
Table 63. Perkinelmer Newborn Screening for SMA and SCID Product Overview
Table 64. Perkinelmer Newborn Screening for SMA and SCID Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Perkinelmer Business Overview
Table 66. Perkinelmer SWOT Analysis
Table 67. Perkinelmer Recent Developments
Table 68. Thermo Fisher Basic Information
Table 69. Thermo Fisher Newborn Screening for SMA and SCID Product Overview
Table 70. Thermo Fisher Newborn Screening for SMA and SCID Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Thermo Fisher Business Overview
Table 72. Thermo Fisher SWOT Analysis
Table 73. Thermo Fisher Recent Developments
Table 74. ImmunoIVD Basic Information
Table 75. ImmunoIVD Newborn Screening for SMA and SCID Product Overview
Table 76. ImmunoIVD Newborn Screening for SMA and SCID Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. ImmunoIVD Business Overview
Table 78. ImmunoIVD SWOT Analysis
Table 79. ImmunoIVD Recent Developments
Table 80. Labsystems Diagnostics Basic Information
Table 81. Labsystems Diagnostics Newborn Screening for SMA and SCID Product Overview
Table 82. Labsystems Diagnostics Newborn Screening for SMA and SCID Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Labsystems Diagnostics Business Overview
Table 84. Labsystems Diagnostics Recent Developments
Table 85. Global Newborn Screening for SMA and SCID Sales Forecast by Region (2026-2035) & (K MT)
Table 86. Global Newborn Screening for SMA and SCID Market Size Forecast by Region (2026-2035) & (M USD)
Table 87. North America Newborn Screening for SMA and SCID Sales Forecast by Country (2026-2035) & (K MT)
Table 88. North America Newborn Screening for SMA and SCID Market Size Forecast by Country (2026-2035) & (M USD)
Table 89. Europe Newborn Screening for SMA and SCID Sales Forecast by Country (2026-2035) & (K MT)
Table 90. Europe Newborn Screening for SMA and SCID Market Size Forecast by Country (2026-2035) & (M USD)
Table 91. Asia Pacific Newborn Screening for SMA and SCID Sales Forecast by Region (2026-2035) & (K MT)
Table 92. Asia Pacific Newborn Screening for SMA and SCID Market Size Forecast by Region (2026-2035) & (M USD)
Table 93. South America Newborn Screening for SMA and SCID Sales Forecast by Country (2026-2035) & (K MT)
Table 94. South America Newborn Screening for SMA and SCID Market Size Forecast by Country (2026-2035) & (M USD)
Table 95. Middle East and Africa Newborn Screening for SMA and SCID Sales Forecast by Country (2026-2035) & (Units)
Table 96. Middle East and Africa Newborn Screening for SMA and SCID Market Size Forecast by Country (2026-2035) & (M USD)
Table 97. Global Newborn Screening for SMA and SCID Sales Forecast by Type (2026-2035) & (K MT)
Table 98. Global Newborn Screening for SMA and SCID Market Size Forecast by Type (2026-2035) & (M USD)
Table 99. Global Newborn Screening for SMA and SCID Price Forecast by Type (2026-2035) & (USD/KG)
Table 100. Global Newborn Screening for SMA and SCID Sales (K MT) Forecast by Application (2026-2035)
Table 101. Global Newborn Screening for SMA and SCID Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Newborn Screening for SMA and SCID Market Size by Type (M USD)
Table 4. Global Newborn Screening for SMA and SCID Market Size by Application
Table 5. Newborn Screening for SMA and SCID Market Size Comparison by Region (M USD)
Table 6. Global Newborn Screening for SMA and SCID Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Newborn Screening for SMA and SCID Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Newborn Screening for SMA and SCID Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Newborn Screening for SMA and SCID Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Screening for SMA and SCID as of 2025)
Table 11. Global Market Newborn Screening for SMA and SCID Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Newborn Screening for SMA and SCID Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Newborn Screening for SMA and SCID Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Newborn Screening for SMA and SCID Sales by Type (K MT)
Table 27. Global Newborn Screening for SMA and SCID Market Size by Type (M USD)
Table 28. Global Newborn Screening for SMA and SCID Sales (K MT) by Type (2020-2025)
Table 29. Global Newborn Screening for SMA and SCID Sales Market Share by Type (2020-2025)
Table 30. Global Newborn Screening for SMA and SCID Market Size (M USD) by Type (2020-2025)
Table 31. Global Newborn Screening for SMA and SCID Market Share by Type (2020-2025)
Table 32. Global Newborn Screening for SMA and SCID Price (USD/KG) by Type (2020-2025)
Table 33. Global Newborn Screening for SMA and SCID Sales (K MT) by Application
Table 34. Global Newborn Screening for SMA and SCID Market Size by Application
Table 35. Global Newborn Screening for SMA and SCID Sales by Application (2020-2025) & (K MT)
Table 36. Global Newborn Screening for SMA and SCID Sales Market Share by Application (2020-2025)
Table 37. Global Newborn Screening for SMA and SCID Market Size by Application (2020-2025) & (M USD)
Table 38. Global Newborn Screening for SMA and SCID Market Share by Application (2020-2025)
Table 39. Global Newborn Screening for SMA and SCID Sales Growth Rate by Application (2020-2025)
Table 40. Global Newborn Screening for SMA and SCID Sales by Region (2020-2025) & (K MT)
Table 41. Global Newborn Screening for SMA and SCID Sales Market Share by Region (2020-2025)
Table 42. Global Newborn Screening for SMA and SCID Market Size by Region (2020-2025) & (M USD)
Table 43. Global Newborn Screening for SMA and SCID Market Size by Region (2020-2025)
Table 44. North America Newborn Screening for SMA and SCID Sales by Country (2020-2025) & (K MT)
Table 45. North America Newborn Screening for SMA and SCID Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Newborn Screening for SMA and SCID Sales by Country (2020-2025) & (K MT)
Table 47. Europe Newborn Screening for SMA and SCID Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Newborn Screening for SMA and SCID Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Newborn Screening for SMA and SCID Market Size by Region (2020-2025) & (M USD)
Table 50. South America Newborn Screening for SMA and SCID Sales by Country (2020-2025) & (K MT)
Table 51. South America Newborn Screening for SMA and SCID Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Newborn Screening for SMA and SCID Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Newborn Screening for SMA and SCID Market Size by Region (2020-2025) & (M USD)
Table 54. Global Newborn Screening for SMA and SCID Production (K MT) by Region(2020-2025)
Table 55. Global Newborn Screening for SMA and SCID Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Newborn Screening for SMA and SCID Revenue Market Share by Region (2020-2025)
Table 57. Global Newborn Screening for SMA and SCID Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Newborn Screening for SMA and SCID Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Newborn Screening for SMA and SCID Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Newborn Screening for SMA and SCID Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Newborn Screening for SMA and SCID Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Perkinelmer Basic Information
Table 63. Perkinelmer Newborn Screening for SMA and SCID Product Overview
Table 64. Perkinelmer Newborn Screening for SMA and SCID Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Perkinelmer Business Overview
Table 66. Perkinelmer SWOT Analysis
Table 67. Perkinelmer Recent Developments
Table 68. Thermo Fisher Basic Information
Table 69. Thermo Fisher Newborn Screening for SMA and SCID Product Overview
Table 70. Thermo Fisher Newborn Screening for SMA and SCID Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Thermo Fisher Business Overview
Table 72. Thermo Fisher SWOT Analysis
Table 73. Thermo Fisher Recent Developments
Table 74. ImmunoIVD Basic Information
Table 75. ImmunoIVD Newborn Screening for SMA and SCID Product Overview
Table 76. ImmunoIVD Newborn Screening for SMA and SCID Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. ImmunoIVD Business Overview
Table 78. ImmunoIVD SWOT Analysis
Table 79. ImmunoIVD Recent Developments
Table 80. Labsystems Diagnostics Basic Information
Table 81. Labsystems Diagnostics Newborn Screening for SMA and SCID Product Overview
Table 82. Labsystems Diagnostics Newborn Screening for SMA and SCID Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Labsystems Diagnostics Business Overview
Table 84. Labsystems Diagnostics Recent Developments
Table 85. Global Newborn Screening for SMA and SCID Sales Forecast by Region (2026-2035) & (K MT)
Table 86. Global Newborn Screening for SMA and SCID Market Size Forecast by Region (2026-2035) & (M USD)
Table 87. North America Newborn Screening for SMA and SCID Sales Forecast by Country (2026-2035) & (K MT)
Table 88. North America Newborn Screening for SMA and SCID Market Size Forecast by Country (2026-2035) & (M USD)
Table 89. Europe Newborn Screening for SMA and SCID Sales Forecast by Country (2026-2035) & (K MT)
Table 90. Europe Newborn Screening for SMA and SCID Market Size Forecast by Country (2026-2035) & (M USD)
Table 91. Asia Pacific Newborn Screening for SMA and SCID Sales Forecast by Region (2026-2035) & (K MT)
Table 92. Asia Pacific Newborn Screening for SMA and SCID Market Size Forecast by Region (2026-2035) & (M USD)
Table 93. South America Newborn Screening for SMA and SCID Sales Forecast by Country (2026-2035) & (K MT)
Table 94. South America Newborn Screening for SMA and SCID Market Size Forecast by Country (2026-2035) & (M USD)
Table 95. Middle East and Africa Newborn Screening for SMA and SCID Sales Forecast by Country (2026-2035) & (Units)
Table 96. Middle East and Africa Newborn Screening for SMA and SCID Market Size Forecast by Country (2026-2035) & (M USD)
Table 97. Global Newborn Screening for SMA and SCID Sales Forecast by Type (2026-2035) & (K MT)
Table 98. Global Newborn Screening for SMA and SCID Market Size Forecast by Type (2026-2035) & (M USD)
Table 99. Global Newborn Screening for SMA and SCID Price Forecast by Type (2026-2035) & (USD/KG)
Table 100. Global Newborn Screening for SMA and SCID Sales (K MT) Forecast by Application (2026-2035)
Table 101. Global Newborn Screening for SMA and SCID Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Newborn Screening for SMA and SCID
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Newborn Screening for SMA and SCID Market Size (M USD), 2025-2035
Figure 5. Global Newborn Screening for SMA and SCID Market Size (M USD) (2020-2035)
Figure 6. Global Newborn Screening for SMA and SCID Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Newborn Screening for SMA and SCID Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Newborn Screening for SMA and SCID Product Life Cycle
Figure 13. Newborn Screening for SMA and SCID Sales Share by Manufacturers in 2025
Figure 14. Global Newborn Screening for SMA and SCID Revenue Share by Manufacturers in 2025
Figure 15. Newborn Screening for SMA and SCID Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Newborn Screening for SMA and SCID Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Newborn Screening for SMA and SCID Revenue in 2025
Figure 18. Industry Chain Map of Newborn Screening for SMA and SCID
Figure 19. Global Newborn Screening for SMA and SCID Market PEST Analysis
Figure 20. Global Newborn Screening for SMA and SCID Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Newborn Screening for SMA and SCID Market Share by Type
Figure 27. Sales Market Share of Newborn Screening for SMA and SCID by Type (2020-2025)
Figure 28. Sales Market Share of Newborn Screening for SMA and SCID by Type in 2025
Figure 29. Market Share of Newborn Screening for SMA and SCID by Type (2020-2025)
Figure 30. Market Share of Newborn Screening for SMA and SCID by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Newborn Screening for SMA and SCID Market Share by Application
Figure 33. Global Newborn Screening for SMA and SCID Sales Market Share by Application (2020-2025)
Figure 34. Global Newborn Screening for SMA and SCID Sales Market Share by Application in 2025
Figure 35. Global Newborn Screening for SMA and SCID Market Share by Application (2020-2025)
Figure 36. Global Newborn Screening for SMA and SCID Market Share by Application in 2025
Figure 37. Global Newborn Screening for SMA and SCID Sales Growth Rate by Application (2020-2025)
Figure 38. Global Newborn Screening for SMA and SCID Sales Market Share by Region (2020-2025)
Figure 39. Global Newborn Screening for SMA and SCID Market Size by Region (2020-2025)
Figure 40. North America Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Newborn Screening for SMA and SCID Sales Market Share by Country in 2024
Figure 43. North America Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Newborn Screening for SMA and SCID Market Size by Country in 2024
Figure 45. U.S. Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Newborn Screening for SMA and SCID Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Newborn Screening for SMA and SCID Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Newborn Screening for SMA and SCID Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Newborn Screening for SMA and SCID Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Newborn Screening for SMA and SCID Sales Market Share by Country in 2024
Figure 53. Europe Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Newborn Screening for SMA and SCID Market Size by Country in 2024
Figure 55. Germany Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Newborn Screening for SMA and SCID Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Newborn Screening for SMA and SCID Sales Market Share by Region in 2024
Figure 67. Asia Pacific Newborn Screening for SMA and SCID Market Size by Region in 2024
Figure 68. China Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Newborn Screening for SMA and SCID Sales and Growth Rate (K MT)
Figure 79. South America Newborn Screening for SMA and SCID Sales Market Share by Country in 2024
Figure 80. South America Newborn Screening for SMA and SCID Market Size and Growth Rate (M USD)
Figure 81. South America Newborn Screening for SMA and SCID Market Size by Country in 2024
Figure 82. Brazil Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Newborn Screening for SMA and SCID Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Newborn Screening for SMA and SCID Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Newborn Screening for SMA and SCID Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Newborn Screening for SMA and SCID Market Size by Region in 2024
Figure 92. Saudi Arabia Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Newborn Screening for SMA and SCID Production Market Share by Region (2020-2025)
Figure 103. North America Newborn Screening for SMA and SCID Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Newborn Screening for SMA and SCID Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Newborn Screening for SMA and SCID Production (K MT) Growth Rate (2020-2025)
Figure 106. China Newborn Screening for SMA and SCID Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Newborn Screening for SMA and SCID Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Newborn Screening for SMA and SCID Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Newborn Screening for SMA and SCID Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Newborn Screening for SMA and SCID Market Share Forecast by Type (2026-2035)
Figure 111. Global Newborn Screening for SMA and SCID Sales Forecast by Application (2026-2035)
Figure 112. Global Newborn Screening for SMA and SCID Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Newborn Screening for SMA and SCID
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Newborn Screening for SMA and SCID Market Size (M USD), 2025-2035
Figure 5. Global Newborn Screening for SMA and SCID Market Size (M USD) (2020-2035)
Figure 6. Global Newborn Screening for SMA and SCID Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Newborn Screening for SMA and SCID Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Newborn Screening for SMA and SCID Product Life Cycle
Figure 13. Newborn Screening for SMA and SCID Sales Share by Manufacturers in 2025
Figure 14. Global Newborn Screening for SMA and SCID Revenue Share by Manufacturers in 2025
Figure 15. Newborn Screening for SMA and SCID Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Newborn Screening for SMA and SCID Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Newborn Screening for SMA and SCID Revenue in 2025
Figure 18. Industry Chain Map of Newborn Screening for SMA and SCID
Figure 19. Global Newborn Screening for SMA and SCID Market PEST Analysis
Figure 20. Global Newborn Screening for SMA and SCID Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Newborn Screening for SMA and SCID Market Share by Type
Figure 27. Sales Market Share of Newborn Screening for SMA and SCID by Type (2020-2025)
Figure 28. Sales Market Share of Newborn Screening for SMA and SCID by Type in 2025
Figure 29. Market Share of Newborn Screening for SMA and SCID by Type (2020-2025)
Figure 30. Market Share of Newborn Screening for SMA and SCID by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Newborn Screening for SMA and SCID Market Share by Application
Figure 33. Global Newborn Screening for SMA and SCID Sales Market Share by Application (2020-2025)
Figure 34. Global Newborn Screening for SMA and SCID Sales Market Share by Application in 2025
Figure 35. Global Newborn Screening for SMA and SCID Market Share by Application (2020-2025)
Figure 36. Global Newborn Screening for SMA and SCID Market Share by Application in 2025
Figure 37. Global Newborn Screening for SMA and SCID Sales Growth Rate by Application (2020-2025)
Figure 38. Global Newborn Screening for SMA and SCID Sales Market Share by Region (2020-2025)
Figure 39. Global Newborn Screening for SMA and SCID Market Size by Region (2020-2025)
Figure 40. North America Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Newborn Screening for SMA and SCID Sales Market Share by Country in 2024
Figure 43. North America Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Newborn Screening for SMA and SCID Market Size by Country in 2024
Figure 45. U.S. Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Newborn Screening for SMA and SCID Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Newborn Screening for SMA and SCID Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Newborn Screening for SMA and SCID Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Newborn Screening for SMA and SCID Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Newborn Screening for SMA and SCID Sales Market Share by Country in 2024
Figure 53. Europe Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Newborn Screening for SMA and SCID Market Size by Country in 2024
Figure 55. Germany Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Newborn Screening for SMA and SCID Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Newborn Screening for SMA and SCID Sales Market Share by Region in 2024
Figure 67. Asia Pacific Newborn Screening for SMA and SCID Market Size by Region in 2024
Figure 68. China Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Newborn Screening for SMA and SCID Sales and Growth Rate (K MT)
Figure 79. South America Newborn Screening for SMA and SCID Sales Market Share by Country in 2024
Figure 80. South America Newborn Screening for SMA and SCID Market Size and Growth Rate (M USD)
Figure 81. South America Newborn Screening for SMA and SCID Market Size by Country in 2024
Figure 82. Brazil Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Newborn Screening for SMA and SCID Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Newborn Screening for SMA and SCID Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Newborn Screening for SMA and SCID Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Newborn Screening for SMA and SCID Market Size by Region in 2024
Figure 92. Saudi Arabia Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Newborn Screening for SMA and SCID Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Newborn Screening for SMA and SCID Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Newborn Screening for SMA and SCID Production Market Share by Region (2020-2025)
Figure 103. North America Newborn Screening for SMA and SCID Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Newborn Screening for SMA and SCID Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Newborn Screening for SMA and SCID Production (K MT) Growth Rate (2020-2025)
Figure 106. China Newborn Screening for SMA and SCID Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Newborn Screening for SMA and SCID Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Newborn Screening for SMA and SCID Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Newborn Screening for SMA and SCID Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Newborn Screening for SMA and SCID Market Share Forecast by Type (2026-2035)
Figure 111. Global Newborn Screening for SMA and SCID Sales Forecast by Application (2026-2035)
Figure 112. Global Newborn Screening for SMA and SCID Market Share Forecast by Application (2026-2035)
